{
  "study": "42847922MDD3003",
  "report_id": 92,
  "forms": [
    "Acknowledgement Reporting Form",
    "Acknowledgement Upload Form",
    "Adverse Event of Special Interest",
    "Adverse Events/Serious Aes",
    "Alcohol Test",
    "Arizona Sexual Experiences Scale Summary",
    "Arizona Sexual Experiences Scale-Female",
    "Arizona Sexual Experiences Scale-Male",
    "Change in Background Antidepressant",
    "Clinical Global Impression - S (Depression)",
    "Clinical Outcome Assessments Completion Status",
    "Columbia-Suicide Severity Rating Scale - Baseline/Screening Version",
    "Columbia-Suicide Severity Rating Scale - Since Last Visit",
    "Comments",
    "Concomitant Therapy / Medication",
    "Date of Visit",
    "Death Information",
    "Demographics",
    "Derivation (operational form)",
    "Drug Expiry Information",
    "Drug Testing",
    "DSL Index Page (Must have for DSL functionality; not visible to the sites) (operational form)",
    "DUMMY (operational form)",
    "Educational Level",
    "Enrollment",
    "EQ-5D-5L",
    "Evaluation of Response - Induction Phase",
    "Evaluation of Response - Stabilization Phase",
    "General Medical History",
    "Inclusion/Exclusion Criteria",
    "Insomnia Severity Index",
    "Insomnia Severity Index (Clinician Version)",
    "Integrated Medication Kit Accountability Information Double Blind Maintenance",
    "Integrated Medication Kit Accountability Information Double Blind Part 1",
    "Integrated Medication Kit Accountability Information Open Label Part 2",
    "Interim Investigator Signature",
    "IRT Stratification",
    "Local Chemistry (Unscheduled)",
    "Local Hematology (Unscheduled)",
    "Local Labs for Background Antidepressant Compliance",
    "Menstrual Cycle Tracking",
    "Menstrual Cycle Tracking Log",
    "MGH ATRQ, Geriatric, Section I and II",
    "MGH ATRQ, Non-Geriatric, Section I and II",
    "MGH-ATRQ - Summary",
    "MGH-ATRQ - Therapy Questions",
    "Mini-Mental State Examination",
    "Neurologic Examination",
    "Patient Global Impression of Change - Depression/Insomnia",
    "Patient Global Impression of Severity - Insomnia",
    "Patient Health Questionnaire - 9 Item",
    "Perceived Treatment Group Assignment",
    "Periodic Investigator's EDC Review Acknowledgement",
    "Physical Examination",
    "Physician Withdrawal Checklist (PWC)",
    "Pregnancy Test",
    "Preplanned Surgeries/Procedures",
    "Procedures",
    "PROMIS - Sleep Disturbance",
    "Protocol Amendment Implementation (Operational Form)",
    "Psychiatric History for Major Depressive Disorder",
    "Psychotherapy",
    "Psychotherapy v2.0",
    "Randomization",
    "Relapse - MAJOR DEPRESSIVE DISORDER",
    "Relapse Criteria",
    "Relapse Criteria Unscheduled",
    "Relevant Additional Drug Therapies",
    "Relevant information Selection",
    "Relevant Local Laboratory",
    "Relevant Local Laboratory Data",
    "Relevant Medical History",
    "Relevant Preplanned Surgeries/Procedures",
    "Relevant Procedures",
    "Relevant Study Medication",
    "Relevant Tests",
    "Safety Report Form",
    "SCID-CT",
    "SCID-CT Insomnia Disorder Supplemental",
    "Sheehan Disability Scale",
    "SIGH-D-17",
    "Site Independent Qualification Assessment",
    "Site/Invest Identification",
    "Structured Interview Guide for the Montgomery-Asberg Depression Rating Scale",
    "Study Drug Administration Double Blind Maintenance",
    "Study Drug Administration Double Blind Part 1",
    "Study Drug Administration Open Label Part 2 - Induction",
    "Study Drug Administration Open Label Part 2 - Stabilization",
    "Subject",
    "Subject Site Switch",
    "Treatment Disposition",
    "Treatment Unblinding",
    "Trial Disposition Completion/ Discontinuation",
    "Unscheduled Assessments",
    "Unsuccessful Contact Attempts",
    "Vital Signs",
    "Vital Signs (Unscheduled)"
  ]
}
